Genetics

	09/10/2009	Genetic Prognostic Testing for Adolescent Idiopathic Scoliosis
	08/27/2009	Alpha1-Antitrypsin Augmentation: Approaches and Benefits
	05/19/2009	Optimizing the Use of Chemotherapy as the Backbone of Breast Cancer Treatment: An Update of the Latest Evidence
	01/29/2009	A Genome-Wide Association Study Exploring Statin-Induced Myopathy
	10/08/2008	Prothrombotic States
	10/03/2008	Progress in Detecting and Managing HER2-Positive Breast Cancer: A Brief Clinical Update
	09/16/2008	Genetics of Cardiac Arrhythmias: Implications for Therapy
	09/08/2008	VKORC Gene Test for Coumadin Dosage
	08/26/2008	Alpha1-Antitrypsin Deficiency: Incidence, Screening, and Management
	08/26/2008	Early Detection of Alpha1-Antitrypsin (AAT) Deficiency Helps Prevent Disease Progression
	08/26/2008	What Is the Best Approach to Treating Alpha1-Antitrypsin (AAT) Deficiency?
	07/22/2008	Genetic Analysis of Coronary Heart Disease
	05/12/2008	Epigenetic Alterations as Targets of Therapy in Myelodysplastic Syndromes: Applying Science to Clinical Practice
	05/12/2008	Epigenomic Modification as a Therapeutic Strategy in Myelodysplasia: What Is the Rationale?
	05/12/2008	DNA Hypomethylating Agents Can Alter Natural History of Myelodysplastic Syndromes
	05/12/2008	DNA Hypomethylating Agents Associated With Manageable Toxicities in the Treatment of Myelodysplasia
	04/10/2008	Beyond Efficacy and Safety in Rheumatoid Arthritis Treatment: Quality-of-Life Outcomes With Newer Biologics in RA
	04/10/2008	Long-Term Data on Abatacept and Rituximab Show Continued Efficacy in Rheumatoid Arthritis
	04/10/2008	Are Rituximab and Abatacept Safe Over the Long Term in Rheumatoid Arthritis?
	04/10/2008	Functional Assessment Effectively Measures Therapeutic Success in Rheumatoid Arthritis
	04/10/2008	Can HRQOL Be Sustained in the Long Term With Abatacept and Rituximab?
	02/21/2008	HER2 Testing in Breast Cancer: Where Do We Presently Stand?
	02/21/2008	HER2 Testing in Breast Cancer: Will Multigene Arrays Be the Standard in Future?
	01/31/2008	Diagnosing Fibromyalgia: Defining Characteristics and Risk Factors
	01/31/2008	Understanding Resistance to Imatinib in Chronic Myelogenous Leukaemia
	01/31/2008	Interpreting the Science: Clinical Implications of the Latest Research in Fibromyalgia
	01/31/2008	Resistance Is Futile: How New Tyrosine Kinase Inhibitors Extend Treatment Options in Chronic Myeloid Leukaemia
	01/31/2008	Integrating Treatment Approaches to Fibromyalgia
	01/31/2008	Strategies to Improve the Use of Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukaemia
	01/23/2008	Overcoming Challenges in the Management of Metastatic Breast Cancer